nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—ABCB1—Mitomycin—stomach cancer	0.0903	0.155	CbGbCtD
Fluvoxamine—CYP3A7—Irinotecan—stomach cancer	0.0475	0.0815	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0475	0.0815	CbGbCtD
Fluvoxamine—CYP2B6—Irinotecan—stomach cancer	0.0452	0.0776	CbGbCtD
Fluvoxamine—CYP2C9—Capecitabine—stomach cancer	0.0387	0.0664	CbGbCtD
Fluvoxamine—CYP3A5—Irinotecan—stomach cancer	0.0356	0.0612	CbGbCtD
Fluvoxamine—CYP3A7—Docetaxel—stomach cancer	0.0348	0.0598	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0348	0.0598	CbGbCtD
Fluvoxamine—CYP3A5—Docetaxel—stomach cancer	0.0261	0.0448	CbGbCtD
Fluvoxamine—CYP1A2—Fluorouracil—stomach cancer	0.0254	0.0437	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—stomach cancer	0.0247	0.0424	CbGbCtD
Fluvoxamine—ABCB1—Irinotecan—stomach cancer	0.0232	0.0398	CbGbCtD
Fluvoxamine—CYP2C9—Fluorouracil—stomach cancer	0.0229	0.0394	CbGbCtD
Fluvoxamine—ABCB1—Docetaxel—stomach cancer	0.017	0.0292	CbGbCtD
Fluvoxamine—CYP3A4—Irinotecan—stomach cancer	0.0139	0.0239	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—stomach cancer	0.0127	0.0217	CbGbCtD
Fluvoxamine—ABCB1—Methotrexate—stomach cancer	0.0123	0.0211	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—stomach cancer	0.0119	0.0205	CbGbCtD
Fluvoxamine—CYP3A4—Docetaxel—stomach cancer	0.0102	0.0175	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—stomach cancer	0.00759	0.013	CbGbCtD
Fluvoxamine—SLC6A3—hematopoietic system—stomach cancer	0.00112	0.0359	CbGeAlD
Fluvoxamine—CYP3A7—endocrine gland—stomach cancer	0.00109	0.035	CbGeAlD
Fluvoxamine—SLC6A4—hematopoietic system—stomach cancer	0.00102	0.0329	CbGeAlD
Fluvoxamine—CYP3A7—liver—stomach cancer	0.000984	0.0316	CbGeAlD
Fluvoxamine—SIGMAR1—smooth muscle tissue—stomach cancer	0.000896	0.0287	CbGeAlD
Fluvoxamine—CYP2C19—hematopoietic system—stomach cancer	0.000849	0.0272	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—liver—stomach cancer	0.000837	0.0268	CbGeAlD
Fluvoxamine—SIGMAR1—pancreas—stomach cancer	0.000828	0.0266	CbGeAlD
Fluvoxamine—SLC6A4—digestive system—stomach cancer	0.000712	0.0229	CbGeAlD
Fluvoxamine—CYP1A2—hematopoietic system—stomach cancer	0.000693	0.0222	CbGeAlD
Fluvoxamine—CYP1A1—hematopoietic system—stomach cancer	0.000684	0.0219	CbGeAlD
Fluvoxamine—CYP3A5—hematopoietic system—stomach cancer	0.000669	0.0215	CbGeAlD
Fluvoxamine—ABCB1—blood vessel—stomach cancer	0.000667	0.0214	CbGeAlD
Fluvoxamine—CYP2B6—hematopoietic system—stomach cancer	0.000665	0.0213	CbGeAlD
Fluvoxamine—CYP2C9—hematopoietic system—stomach cancer	0.000658	0.0211	CbGeAlD
Fluvoxamine—SIGMAR1—bone marrow—stomach cancer	0.000652	0.0209	CbGeAlD
Fluvoxamine—CYP1A1—epithelium—stomach cancer	0.000625	0.0201	CbGeAlD
Fluvoxamine—CYP2E1—hematopoietic system—stomach cancer	0.000624	0.02	CbGeAlD
Fluvoxamine—CYP2C19—digestive system—stomach cancer	0.00059	0.0189	CbGeAlD
Fluvoxamine—SLC6A4—endocrine gland—stomach cancer	0.000589	0.0189	CbGeAlD
Fluvoxamine—CYP3A5—pancreas—stomach cancer	0.000544	0.0175	CbGeAlD
Fluvoxamine—SIGMAR1—liver—stomach cancer	0.000527	0.0169	CbGeAlD
Fluvoxamine—CYP3A4—hematopoietic system—stomach cancer	0.000502	0.0161	CbGeAlD
Fluvoxamine—CYP2D6—hematopoietic system—stomach cancer	0.000494	0.0158	CbGeAlD
Fluvoxamine—CYP2C19—endocrine gland—stomach cancer	0.000488	0.0156	CbGeAlD
Fluvoxamine—CYP1A2—digestive system—stomach cancer	0.000482	0.0155	CbGeAlD
Fluvoxamine—CYP1A1—digestive system—stomach cancer	0.000476	0.0153	CbGeAlD
Fluvoxamine—CYP2B6—lymphoid tissue—stomach cancer	0.000468	0.015	CbGeAlD
Fluvoxamine—CYP3A5—digestive system—stomach cancer	0.000465	0.0149	CbGeAlD
Fluvoxamine—CYP2B6—digestive system—stomach cancer	0.000462	0.0148	CbGeAlD
Fluvoxamine—CYP2C9—digestive system—stomach cancer	0.000458	0.0147	CbGeAlD
Fluvoxamine—CYP2C19—liver—stomach cancer	0.00044	0.0141	CbGeAlD
Fluvoxamine—CYP2E1—lymphoid tissue—stomach cancer	0.000439	0.0141	CbGeAlD
Fluvoxamine—CYP2E1—digestive system—stomach cancer	0.000434	0.0139	CbGeAlD
Fluvoxamine—SIGMAR1—lymph node—stomach cancer	0.000404	0.013	CbGeAlD
Fluvoxamine—CYP1A2—endocrine gland—stomach cancer	0.000398	0.0128	CbGeAlD
Fluvoxamine—CYP1A1—endocrine gland—stomach cancer	0.000393	0.0126	CbGeAlD
Fluvoxamine—CYP3A5—endocrine gland—stomach cancer	0.000384	0.0123	CbGeAlD
Fluvoxamine—CYP2B6—endocrine gland—stomach cancer	0.000382	0.0123	CbGeAlD
Fluvoxamine—CYP2C9—endocrine gland—stomach cancer	0.000378	0.0121	CbGeAlD
Fluvoxamine—CYP1A2—liver—stomach cancer	0.000359	0.0115	CbGeAlD
Fluvoxamine—CYP2E1—endocrine gland—stomach cancer	0.000358	0.0115	CbGeAlD
Fluvoxamine—ABCB1—hematopoietic system—stomach cancer	0.000355	0.0114	CbGeAlD
Fluvoxamine—CYP1A1—liver—stomach cancer	0.000354	0.0114	CbGeAlD
Fluvoxamine—CYP3A4—digestive system—stomach cancer	0.000349	0.0112	CbGeAlD
Fluvoxamine—CYP3A5—liver—stomach cancer	0.000346	0.0111	CbGeAlD
Fluvoxamine—CYP2B6—liver—stomach cancer	0.000344	0.011	CbGeAlD
Fluvoxamine—CYP2D6—digestive system—stomach cancer	0.000343	0.011	CbGeAlD
Fluvoxamine—CYP2C9—liver—stomach cancer	0.000341	0.0109	CbGeAlD
Fluvoxamine—ABCB1—epithelium—stomach cancer	0.000325	0.0104	CbGeAlD
Fluvoxamine—CYP2E1—liver—stomach cancer	0.000323	0.0104	CbGeAlD
Fluvoxamine—ABCB1—pancreas—stomach cancer	0.000289	0.00928	CbGeAlD
Fluvoxamine—CYP3A4—endocrine gland—stomach cancer	0.000288	0.00925	CbGeAlD
Fluvoxamine—CYP2D6—endocrine gland—stomach cancer	0.000284	0.0091	CbGeAlD
Fluvoxamine—CYP1A1—lymph node—stomach cancer	0.000272	0.00871	CbGeAlD
Fluvoxamine—CYP3A4—liver—stomach cancer	0.00026	0.00834	CbGeAlD
Fluvoxamine—CYP2D6—liver—stomach cancer	0.000256	0.00821	CbGeAlD
Fluvoxamine—ABCB1—lymphoid tissue—stomach cancer	0.00025	0.00802	CbGeAlD
Fluvoxamine—ABCB1—digestive system—stomach cancer	0.000247	0.00792	CbGeAlD
Fluvoxamine—ABCB1—bone marrow—stomach cancer	0.000228	0.0073	CbGeAlD
Fluvoxamine—ABCB1—endocrine gland—stomach cancer	0.000204	0.00655	CbGeAlD
Fluvoxamine—ABCB1—liver—stomach cancer	0.000184	0.0059	CbGeAlD
Fluvoxamine—ABCB1—lymph node—stomach cancer	0.000141	0.00453	CbGeAlD
Fluvoxamine—Malnutrition—Methotrexate—stomach cancer	0.00011	0.000347	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—stomach cancer	0.00011	0.000346	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00011	0.000346	CcSEcCtD
Fluvoxamine—Cardiac disorder—Epirubicin—stomach cancer	0.000109	0.000346	CcSEcCtD
Fluvoxamine—Vomiting—Fluorouracil—stomach cancer	0.000109	0.000346	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—stomach cancer	0.000109	0.000346	CcSEcCtD
Fluvoxamine—Dyspepsia—Docetaxel—stomach cancer	0.000109	0.000345	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—stomach cancer	0.000109	0.000345	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—stomach cancer	0.000109	0.000345	CcSEcCtD
Fluvoxamine—Insomnia—Capecitabine—stomach cancer	0.000109	0.000344	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000109	0.000343	CcSEcCtD
Fluvoxamine—Rash—Fluorouracil—stomach cancer	0.000108	0.000343	CcSEcCtD
Fluvoxamine—Dermatitis—Fluorouracil—stomach cancer	0.000108	0.000342	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—stomach cancer	0.000108	0.000342	CcSEcCtD
Fluvoxamine—Paraesthesia—Capecitabine—stomach cancer	0.000108	0.000341	CcSEcCtD
Fluvoxamine—Decreased appetite—Docetaxel—stomach cancer	0.000108	0.000341	CcSEcCtD
Fluvoxamine—Headache—Fluorouracil—stomach cancer	0.000108	0.000341	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000108	0.00034	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—stomach cancer	0.000107	0.00034	CcSEcCtD
Fluvoxamine—Dysgeusia—Methotrexate—stomach cancer	0.000107	0.000339	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000107	0.000339	CcSEcCtD
Fluvoxamine—Dyspnoea—Capecitabine—stomach cancer	0.000107	0.000339	CcSEcCtD
Fluvoxamine—Fatigue—Docetaxel—stomach cancer	0.000107	0.000338	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—stomach cancer	0.000107	0.000338	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—stomach cancer	0.000107	0.000338	CcSEcCtD
Fluvoxamine—Nausea—Irinotecan—stomach cancer	0.000107	0.000337	CcSEcCtD
Fluvoxamine—Pain—Docetaxel—stomach cancer	0.000106	0.000336	CcSEcCtD
Fluvoxamine—Constipation—Docetaxel—stomach cancer	0.000106	0.000336	CcSEcCtD
Fluvoxamine—Back pain—Methotrexate—stomach cancer	0.000106	0.000335	CcSEcCtD
Fluvoxamine—Dyspepsia—Capecitabine—stomach cancer	0.000106	0.000334	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—stomach cancer	0.000106	0.000334	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—stomach cancer	0.000105	0.000333	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—stomach cancer	0.000105	0.000332	CcSEcCtD
Fluvoxamine—Decreased appetite—Capecitabine—stomach cancer	0.000104	0.00033	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—stomach cancer	0.000104	0.000329	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000104	0.000328	CcSEcCtD
Fluvoxamine—Fatigue—Capecitabine—stomach cancer	0.000104	0.000328	CcSEcCtD
Fluvoxamine—Vision blurred—Methotrexate—stomach cancer	0.000103	0.000327	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—stomach cancer	0.000103	0.000326	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—stomach cancer	0.000103	0.000326	CcSEcCtD
Fluvoxamine—Pain—Capecitabine—stomach cancer	0.000103	0.000325	CcSEcCtD
Fluvoxamine—Constipation—Capecitabine—stomach cancer	0.000103	0.000325	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—stomach cancer	0.000103	0.000324	CcSEcCtD
Fluvoxamine—Feeling abnormal—Docetaxel—stomach cancer	0.000102	0.000323	CcSEcCtD
Fluvoxamine—Nausea—Fluorouracil—stomach cancer	0.000102	0.000323	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—stomach cancer	0.000102	0.000322	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Methotrexate—stomach cancer	0.000102	0.000322	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—stomach cancer	0.000102	0.000321	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000102	0.000321	CcSEcCtD
Fluvoxamine—Anaemia—Methotrexate—stomach cancer	0.000101	0.00032	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—stomach cancer	0.000101	0.00032	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—stomach cancer	0.000101	0.00032	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—stomach cancer	0.000101	0.000318	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—stomach cancer	0.0001	0.000318	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—stomach cancer	9.97e-05	0.000315	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—stomach cancer	9.93e-05	0.000314	CcSEcCtD
Fluvoxamine—Feeling abnormal—Capecitabine—stomach cancer	9.91e-05	0.000313	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—stomach cancer	9.89e-05	0.000313	CcSEcCtD
Fluvoxamine—Malaise—Methotrexate—stomach cancer	9.89e-05	0.000313	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—stomach cancer	9.86e-05	0.000312	CcSEcCtD
Fluvoxamine—Vertigo—Methotrexate—stomach cancer	9.85e-05	0.000311	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Capecitabine—stomach cancer	9.83e-05	0.000311	CcSEcCtD
Fluvoxamine—Abdominal pain—Docetaxel—stomach cancer	9.81e-05	0.00031	CcSEcCtD
Fluvoxamine—Body temperature increased—Docetaxel—stomach cancer	9.81e-05	0.00031	CcSEcCtD
Fluvoxamine—Leukopenia—Methotrexate—stomach cancer	9.81e-05	0.00031	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—stomach cancer	9.79e-05	0.000309	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—stomach cancer	9.74e-05	0.000308	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—stomach cancer	9.67e-05	0.000306	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—stomach cancer	9.64e-05	0.000305	CcSEcCtD
Fluvoxamine—Cough—Methotrexate—stomach cancer	9.57e-05	0.000302	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—stomach cancer	9.55e-05	0.000302	CcSEcCtD
Fluvoxamine—Urticaria—Capecitabine—stomach cancer	9.55e-05	0.000302	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—stomach cancer	9.52e-05	0.000301	CcSEcCtD
Fluvoxamine—Body temperature increased—Capecitabine—stomach cancer	9.5e-05	0.0003	CcSEcCtD
Fluvoxamine—Abdominal pain—Capecitabine—stomach cancer	9.5e-05	0.0003	CcSEcCtD
Fluvoxamine—Convulsion—Methotrexate—stomach cancer	9.5e-05	0.0003	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—stomach cancer	9.49e-05	0.0003	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—stomach cancer	9.48e-05	0.0003	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—stomach cancer	9.43e-05	0.000298	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—stomach cancer	9.36e-05	0.000296	CcSEcCtD
Fluvoxamine—Chest pain—Methotrexate—stomach cancer	9.33e-05	0.000295	CcSEcCtD
Fluvoxamine—Myalgia—Methotrexate—stomach cancer	9.33e-05	0.000295	CcSEcCtD
Fluvoxamine—Arthralgia—Methotrexate—stomach cancer	9.33e-05	0.000295	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—stomach cancer	9.32e-05	0.000294	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—stomach cancer	9.3e-05	0.000294	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—stomach cancer	9.25e-05	0.000292	CcSEcCtD
Fluvoxamine—Discomfort—Methotrexate—stomach cancer	9.22e-05	0.000291	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—stomach cancer	9.22e-05	0.000291	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—stomach cancer	9.22e-05	0.000291	CcSEcCtD
Fluvoxamine—Syncope—Epirubicin—stomach cancer	9.2e-05	0.000291	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—stomach cancer	9.18e-05	0.00029	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—stomach cancer	9.18e-05	0.00029	CcSEcCtD
Fluvoxamine—Hypersensitivity—Docetaxel—stomach cancer	9.15e-05	0.000289	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—stomach cancer	9.13e-05	0.000288	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—stomach cancer	9.07e-05	0.000287	CcSEcCtD
Fluvoxamine—Confusional state—Methotrexate—stomach cancer	9.02e-05	0.000285	CcSEcCtD
Fluvoxamine—Loss of consciousness—Epirubicin—stomach cancer	9.02e-05	0.000285	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—stomach cancer	8.95e-05	0.000283	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Methotrexate—stomach cancer	8.95e-05	0.000283	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—stomach cancer	8.95e-05	0.000283	CcSEcCtD
Fluvoxamine—Asthenia—Docetaxel—stomach cancer	8.91e-05	0.000282	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—stomach cancer	8.89e-05	0.000281	CcSEcCtD
Fluvoxamine—Infection—Methotrexate—stomach cancer	8.89e-05	0.000281	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—stomach cancer	8.86e-05	0.00028	CcSEcCtD
Fluvoxamine—Hypersensitivity—Capecitabine—stomach cancer	8.86e-05	0.00028	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—stomach cancer	8.81e-05	0.000278	CcSEcCtD
Fluvoxamine—Pruritus—Docetaxel—stomach cancer	8.78e-05	0.000278	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methotrexate—stomach cancer	8.78e-05	0.000277	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—stomach cancer	8.77e-05	0.000277	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Methotrexate—stomach cancer	8.76e-05	0.000277	CcSEcCtD
Fluvoxamine—Arthralgia—Epirubicin—stomach cancer	8.74e-05	0.000276	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—stomach cancer	8.74e-05	0.000276	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—stomach cancer	8.74e-05	0.000276	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—stomach cancer	8.72e-05	0.000276	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—stomach cancer	8.71e-05	0.000275	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methotrexate—stomach cancer	8.65e-05	0.000273	CcSEcCtD
Fluvoxamine—Discomfort—Epirubicin—stomach cancer	8.63e-05	0.000273	CcSEcCtD
Fluvoxamine—Asthenia—Capecitabine—stomach cancer	8.62e-05	0.000273	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—stomach cancer	8.56e-05	0.000271	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—stomach cancer	8.54e-05	0.00027	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—stomach cancer	8.53e-05	0.00027	CcSEcCtD
Fluvoxamine—Anorexia—Methotrexate—stomach cancer	8.53e-05	0.00027	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—stomach cancer	8.51e-05	0.000269	CcSEcCtD
Fluvoxamine—Pruritus—Capecitabine—stomach cancer	8.5e-05	0.000269	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—stomach cancer	8.5e-05	0.000269	CcSEcCtD
Fluvoxamine—Diarrhoea—Docetaxel—stomach cancer	8.49e-05	0.000268	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—stomach cancer	8.44e-05	0.000267	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—stomach cancer	8.39e-05	0.000265	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—stomach cancer	8.37e-05	0.000265	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—stomach cancer	8.37e-05	0.000265	CcSEcCtD
Fluvoxamine—Hypotension—Methotrexate—stomach cancer	8.36e-05	0.000264	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—stomach cancer	8.34e-05	0.000264	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—stomach cancer	8.32e-05	0.000263	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—stomach cancer	8.28e-05	0.000262	CcSEcCtD
Fluvoxamine—Shock—Epirubicin—stomach cancer	8.24e-05	0.00026	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—stomach cancer	8.23e-05	0.00026	CcSEcCtD
Fluvoxamine—Diarrhoea—Capecitabine—stomach cancer	8.22e-05	0.00026	CcSEcCtD
Fluvoxamine—Nervous system disorder—Epirubicin—stomach cancer	8.21e-05	0.00026	CcSEcCtD
Fluvoxamine—Dizziness—Docetaxel—stomach cancer	8.21e-05	0.000259	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—stomach cancer	8.2e-05	0.000259	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—stomach cancer	8.2e-05	0.000259	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—stomach cancer	8.17e-05	0.000258	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methotrexate—stomach cancer	8.15e-05	0.000258	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—stomach cancer	8.1e-05	0.000256	CcSEcCtD
Fluvoxamine—Insomnia—Methotrexate—stomach cancer	8.09e-05	0.000256	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—stomach cancer	8.08e-05	0.000255	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—stomach cancer	8.08e-05	0.000255	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—stomach cancer	8.08e-05	0.000255	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—stomach cancer	8.05e-05	0.000255	CcSEcCtD
Fluvoxamine—Paraesthesia—Methotrexate—stomach cancer	8.04e-05	0.000254	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—stomach cancer	7.99e-05	0.000252	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—stomach cancer	7.98e-05	0.000252	CcSEcCtD
Fluvoxamine—Dyspnoea—Methotrexate—stomach cancer	7.98e-05	0.000252	CcSEcCtD
Fluvoxamine—Somnolence—Methotrexate—stomach cancer	7.96e-05	0.000251	CcSEcCtD
Fluvoxamine—Dizziness—Capecitabine—stomach cancer	7.95e-05	0.000251	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—stomach cancer	7.9e-05	0.00025	CcSEcCtD
Fluvoxamine—Vomiting—Docetaxel—stomach cancer	7.89e-05	0.000249	CcSEcCtD
Fluvoxamine—Dyspepsia—Methotrexate—stomach cancer	7.88e-05	0.000249	CcSEcCtD
Fluvoxamine—Rash—Docetaxel—stomach cancer	7.83e-05	0.000247	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—stomach cancer	7.82e-05	0.000247	CcSEcCtD
Fluvoxamine—Dermatitis—Docetaxel—stomach cancer	7.82e-05	0.000247	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—stomach cancer	7.81e-05	0.000247	CcSEcCtD
Fluvoxamine—Decreased appetite—Methotrexate—stomach cancer	7.78e-05	0.000246	CcSEcCtD
Fluvoxamine—Headache—Docetaxel—stomach cancer	7.78e-05	0.000246	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—stomach cancer	7.75e-05	0.000245	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—stomach cancer	7.75e-05	0.000245	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Methotrexate—stomach cancer	7.73e-05	0.000244	CcSEcCtD
Fluvoxamine—Fatigue—Methotrexate—stomach cancer	7.71e-05	0.000244	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—stomach cancer	7.7e-05	0.000243	CcSEcCtD
Fluvoxamine—Pain—Methotrexate—stomach cancer	7.65e-05	0.000242	CcSEcCtD
Fluvoxamine—Vomiting—Capecitabine—stomach cancer	7.64e-05	0.000242	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—stomach cancer	7.63e-05	0.000241	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—stomach cancer	7.62e-05	0.000241	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—stomach cancer	7.6e-05	0.00024	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—stomach cancer	7.59e-05	0.00024	CcSEcCtD
Fluvoxamine—Rash—Capecitabine—stomach cancer	7.58e-05	0.00024	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—stomach cancer	7.57e-05	0.000239	CcSEcCtD
Fluvoxamine—Dermatitis—Capecitabine—stomach cancer	7.57e-05	0.000239	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—stomach cancer	7.56e-05	0.000239	CcSEcCtD
Fluvoxamine—Headache—Capecitabine—stomach cancer	7.53e-05	0.000238	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—stomach cancer	7.52e-05	0.000238	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—stomach cancer	7.49e-05	0.000237	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—stomach cancer	7.47e-05	0.000236	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—stomach cancer	7.44e-05	0.000235	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—stomach cancer	7.39e-05	0.000233	CcSEcCtD
Fluvoxamine—Nausea—Docetaxel—stomach cancer	7.37e-05	0.000233	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methotrexate—stomach cancer	7.37e-05	0.000233	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—stomach cancer	7.37e-05	0.000233	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methotrexate—stomach cancer	7.32e-05	0.000231	CcSEcCtD
Fluvoxamine—Decreased appetite—Epirubicin—stomach cancer	7.28e-05	0.00023	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—stomach cancer	7.24e-05	0.000229	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—stomach cancer	7.23e-05	0.000228	CcSEcCtD
Fluvoxamine—Fatigue—Epirubicin—stomach cancer	7.22e-05	0.000228	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—stomach cancer	7.16e-05	0.000226	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—stomach cancer	7.16e-05	0.000226	CcSEcCtD
Fluvoxamine—Nausea—Capecitabine—stomach cancer	7.14e-05	0.000226	CcSEcCtD
Fluvoxamine—Urticaria—Methotrexate—stomach cancer	7.11e-05	0.000225	CcSEcCtD
Fluvoxamine—Abdominal pain—Methotrexate—stomach cancer	7.07e-05	0.000224	CcSEcCtD
Fluvoxamine—Body temperature increased—Methotrexate—stomach cancer	7.07e-05	0.000224	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	7.06e-05	0.000223	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—stomach cancer	7.01e-05	0.000221	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—stomach cancer	6.96e-05	0.00022	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—stomach cancer	6.91e-05	0.000218	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—stomach cancer	6.9e-05	0.000218	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—stomach cancer	6.89e-05	0.000218	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—stomach cancer	6.85e-05	0.000216	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—stomach cancer	6.82e-05	0.000216	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—stomach cancer	6.74e-05	0.000213	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—stomach cancer	6.69e-05	0.000211	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—stomach cancer	6.68e-05	0.000211	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—stomach cancer	6.65e-05	0.00021	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—stomach cancer	6.63e-05	0.000209	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—stomach cancer	6.63e-05	0.000209	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—stomach cancer	6.62e-05	0.000209	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—stomach cancer	6.62e-05	0.000209	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methotrexate—stomach cancer	6.59e-05	0.000208	CcSEcCtD
Fluvoxamine—Asthenia—Methotrexate—stomach cancer	6.42e-05	0.000203	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—stomach cancer	6.39e-05	0.000202	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—stomach cancer	6.34e-05	0.0002	CcSEcCtD
Fluvoxamine—Pruritus—Methotrexate—stomach cancer	6.33e-05	0.0002	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—stomach cancer	6.17e-05	0.000195	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—stomach cancer	6.16e-05	0.000195	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—stomach cancer	6.13e-05	0.000194	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—stomach cancer	6.13e-05	0.000194	CcSEcCtD
Fluvoxamine—Diarrhoea—Methotrexate—stomach cancer	6.12e-05	0.000194	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—stomach cancer	6.01e-05	0.00019	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—stomach cancer	5.92e-05	0.000187	CcSEcCtD
Fluvoxamine—Dizziness—Methotrexate—stomach cancer	5.92e-05	0.000187	CcSEcCtD
Fluvoxamine—Diarrhoea—Epirubicin—stomach cancer	5.73e-05	0.000181	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—stomach cancer	5.71e-05	0.00018	CcSEcCtD
Fluvoxamine—Vomiting—Methotrexate—stomach cancer	5.69e-05	0.00018	CcSEcCtD
Fluvoxamine—Rash—Methotrexate—stomach cancer	5.64e-05	0.000178	CcSEcCtD
Fluvoxamine—Dermatitis—Methotrexate—stomach cancer	5.64e-05	0.000178	CcSEcCtD
Fluvoxamine—Headache—Methotrexate—stomach cancer	5.61e-05	0.000177	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—stomach cancer	5.56e-05	0.000176	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—stomach cancer	5.54e-05	0.000175	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—stomach cancer	5.48e-05	0.000173	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—stomach cancer	5.32e-05	0.000168	CcSEcCtD
Fluvoxamine—Nausea—Methotrexate—stomach cancer	5.32e-05	0.000168	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—stomach cancer	5.3e-05	0.000168	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—stomach cancer	5.28e-05	0.000167	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—stomach cancer	5.28e-05	0.000167	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—stomach cancer	5.25e-05	0.000166	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—stomach cancer	5.12e-05	0.000162	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—stomach cancer	4.97e-05	0.000157	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—stomach cancer	4.93e-05	0.000156	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—stomach cancer	4.89e-05	0.000154	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—stomach cancer	4.88e-05	0.000154	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—stomach cancer	4.85e-05	0.000153	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—stomach cancer	4.6e-05	0.000145	CcSEcCtD
Fluvoxamine—CYP3A4—Metabolism—CA1—stomach cancer	1.26e-05	0.00018	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CKB—stomach cancer	1.26e-05	0.00018	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—RORA—stomach cancer	1.26e-05	0.00018	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PDHA1—stomach cancer	1.24e-05	0.000176	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ECHS1—stomach cancer	1.24e-05	0.000176	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKR1C3—stomach cancer	1.23e-05	0.000175	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.22e-05	0.000174	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.22e-05	0.000174	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.22e-05	0.000173	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—TYMS—stomach cancer	1.21e-05	0.000172	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALOX5—stomach cancer	1.21e-05	0.000172	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ENO1—stomach cancer	1.2e-05	0.000171	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTM1—stomach cancer	1.2e-05	0.00017	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALDOB—stomach cancer	1.19e-05	0.00017	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLIN2—stomach cancer	1.19e-05	0.000169	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—DPYD—stomach cancer	1.19e-05	0.000169	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALDOB—stomach cancer	1.18e-05	0.000168	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.18e-05	0.000168	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALOX5—stomach cancer	1.18e-05	0.000167	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.18e-05	0.000167	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—FADS1—stomach cancer	1.17e-05	0.000166	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TYMP—stomach cancer	1.17e-05	0.000166	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—DPYD—stomach cancer	1.16e-05	0.000165	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CA2—stomach cancer	1.16e-05	0.000164	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CD44—stomach cancer	1.15e-05	0.000164	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.13e-05	0.000161	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CD44—stomach cancer	1.13e-05	0.000161	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CD44—stomach cancer	1.13e-05	0.00016	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NT5E—stomach cancer	1.13e-05	0.00016	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PGAM1—stomach cancer	1.13e-05	0.00016	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ERCC2—stomach cancer	1.12e-05	0.00016	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.12e-05	0.000159	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.11e-05	0.000158	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALOX5—stomach cancer	1.11e-05	0.000158	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALOX5—stomach cancer	1.1e-05	0.000156	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SREBF2—stomach cancer	1.09e-05	0.000155	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—DPYD—stomach cancer	1.09e-05	0.000155	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—DPYD—stomach cancer	1.08e-05	0.000154	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—RORA—stomach cancer	1.08e-05	0.000153	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.08e-05	0.000153	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLCE1—stomach cancer	1.07e-05	0.000153	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.07e-05	0.000153	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CD44—stomach cancer	1.07e-05	0.000152	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MTHFR—stomach cancer	1.06e-05	0.00015	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTT1—stomach cancer	1.05e-05	0.000149	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2A6—stomach cancer	1.04e-05	0.000148	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.03e-05	0.000147	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—UMPS—stomach cancer	1.03e-05	0.000146	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTT1—stomach cancer	1.02e-05	0.000146	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2A6—stomach cancer	1.01e-05	0.000144	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALDOB—stomach cancer	1.01e-05	0.000144	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKR1C3—stomach cancer	1.01e-05	0.000144	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKR1C3—stomach cancer	9.85e-06	0.00014	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ENO1—stomach cancer	9.83e-06	0.00014	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPP2R1A—stomach cancer	9.81e-06	0.00014	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.81e-06	0.00014	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CAV1—stomach cancer	9.75e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—APOA1—stomach cancer	9.73e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.67e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTT1—stomach cancer	9.65e-06	0.000137	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTP1—stomach cancer	9.63e-06	0.000137	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPP2R1A—stomach cancer	9.61e-06	0.000137	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ENO1—stomach cancer	9.6e-06	0.000137	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPP2R1A—stomach cancer	9.59e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PDHA1—stomach cancer	9.57e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ECHS1—stomach cancer	9.57e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTT1—stomach cancer	9.57e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP2A6—stomach cancer	9.54e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	9.53e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.51e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—HMOX1—stomach cancer	9.49e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2A6—stomach cancer	9.46e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTP1—stomach cancer	9.43e-06	0.000134	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTP1—stomach cancer	9.41e-06	0.000134	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALOX5—stomach cancer	9.4e-06	0.000134	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—HMOX1—stomach cancer	9.3e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKR1C3—stomach cancer	9.28e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—HMOX1—stomach cancer	9.28e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—DPYD—stomach cancer	9.25e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKR1C3—stomach cancer	9.2e-06	0.000131	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPP2R1A—stomach cancer	9.06e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ENO1—stomach cancer	9.04e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TYMP—stomach cancer	9e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—FADS1—stomach cancer	9e-06	0.000128	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	8.98e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ENO1—stomach cancer	8.97e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TYMS—stomach cancer	8.95e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTP1—stomach cancer	8.89e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTM1—stomach cancer	8.85e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.82e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—HMOX1—stomach cancer	8.77e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TYMS—stomach cancer	8.76e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TYMS—stomach cancer	8.75e-06	0.000124	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CD44—stomach cancer	8.72e-06	0.000124	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTM1—stomach cancer	8.66e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTM1—stomach cancer	8.65e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPARG—stomach cancer	8.57e-06	0.000122	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CD44—stomach cancer	8.51e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.46e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SREBF2—stomach cancer	8.43e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.38e-06	0.000119	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—RORA—stomach cancer	8.33e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ERCC2—stomach cancer	8.32e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TYMS—stomach cancer	8.26e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTT1—stomach cancer	8.18e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTM1—stomach cancer	8.17e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ERCC2—stomach cancer	8.15e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ERCC2—stomach cancer	8.13e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2A6—stomach cancer	8.08e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CD44—stomach cancer	8.02e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CD44—stomach cancer	7.95e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKR1C3—stomach cancer	7.86e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—stomach cancer	7.82e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDOB—stomach cancer	7.8e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.72e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—stomach cancer	7.71e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ERCC2—stomach cancer	7.68e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ENO1—stomach cancer	7.66e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—stomach cancer	7.66e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—stomach cancer	7.64e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.54e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPP2R1A—stomach cancer	7.42e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—stomach cancer	7.37e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTP1—stomach cancer	7.27e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALOX5—stomach cancer	7.25e-06	0.000103	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPP2R1A—stomach cancer	7.24e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—stomach cancer	7.22e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAV1—stomach cancer	7.21e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOA1—stomach cancer	7.19e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—stomach cancer	7.17e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DPYD—stomach cancer	7.14e-06	0.000102	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTP1—stomach cancer	7.1e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAV1—stomach cancer	7.06e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAV1—stomach cancer	7.05e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOA1—stomach cancer	7.05e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOA1—stomach cancer	7.03e-06	0.0001	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—stomach cancer	7e-06	9.96e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	6.82e-06	9.7e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CD44—stomach cancer	6.8e-06	9.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TYMS—stomach cancer	6.76e-06	9.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	6.76e-06	9.62e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—stomach cancer	6.74e-06	9.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTP1—stomach cancer	6.69e-06	9.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—stomach cancer	6.68e-06	9.51e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAV1—stomach cancer	6.66e-06	9.47e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOA1—stomach cancer	6.64e-06	9.45e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTP1—stomach cancer	6.63e-06	9.43e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TYMS—stomach cancer	6.6e-06	9.39e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—stomach cancer	6.6e-06	9.38e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.59e-06	9.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—stomach cancer	6.54e-06	9.3e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—stomach cancer	6.52e-06	9.28e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.36e-06	9.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—stomach cancer	6.34e-06	9.02e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTT1—stomach cancer	6.31e-06	8.98e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ERCC2—stomach cancer	6.28e-06	8.94e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2A6—stomach cancer	6.24e-06	8.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TYMS—stomach cancer	6.22e-06	8.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—stomach cancer	6.21e-06	8.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—stomach cancer	6.2e-06	8.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TYMS—stomach cancer	6.17e-06	8.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—stomach cancer	6.15e-06	8.74e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ERCC2—stomach cancer	6.13e-06	8.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—stomach cancer	6.09e-06	8.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKR1C3—stomach cancer	6.07e-06	8.63e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ENO1—stomach cancer	5.91e-06	8.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—stomach cancer	5.91e-06	8.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—stomach cancer	5.85e-06	8.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ERCC2—stomach cancer	5.78e-06	8.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	5.78e-06	8.22e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—stomach cancer	5.77e-06	8.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ERCC2—stomach cancer	5.73e-06	8.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—stomach cancer	5.7e-06	8.11e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTP1—stomach cancer	5.67e-06	8.06e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—stomach cancer	5.59e-06	7.95e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—stomach cancer	5.58e-06	7.94e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—stomach cancer	5.57e-06	7.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—stomach cancer	5.45e-06	7.76e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAV1—stomach cancer	5.45e-06	7.75e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOA1—stomach cancer	5.44e-06	7.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—stomach cancer	5.43e-06	7.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—stomach cancer	5.39e-06	7.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—stomach cancer	5.34e-06	7.6e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—stomach cancer	5.33e-06	7.58e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAV1—stomach cancer	5.32e-06	7.56e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOA1—stomach cancer	5.31e-06	7.55e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TYMS—stomach cancer	5.27e-06	7.49e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—stomach cancer	5.26e-06	7.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CD44—stomach cancer	5.24e-06	7.46e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—stomach cancer	5.21e-06	7.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.21e-06	7.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—stomach cancer	5.03e-06	7.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAV1—stomach cancer	5.01e-06	7.13e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOA1—stomach cancer	5e-06	7.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—stomach cancer	4.99e-06	7.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAV1—stomach cancer	4.97e-06	7.07e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOA1—stomach cancer	4.96e-06	7.05e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ERCC2—stomach cancer	4.9e-06	6.96e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—stomach cancer	4.88e-06	6.95e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—stomach cancer	4.87e-06	6.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—stomach cancer	4.79e-06	6.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.75e-06	6.75e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—stomach cancer	4.68e-06	6.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—stomach cancer	4.6e-06	6.55e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—stomach cancer	4.6e-06	6.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.46e-06	6.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—stomach cancer	4.41e-06	6.27e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTP1—stomach cancer	4.37e-06	6.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—stomach cancer	4.37e-06	6.21e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—stomach cancer	4.31e-06	6.14e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—stomach cancer	4.31e-06	6.13e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAV1—stomach cancer	4.25e-06	6.04e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOA1—stomach cancer	4.24e-06	6.03e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—stomach cancer	4.2e-06	5.98e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—stomach cancer	4.15e-06	5.9e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—stomach cancer	4.12e-06	5.86e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TYMS—stomach cancer	4.07e-06	5.78e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.06e-06	5.77e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—stomach cancer	4.02e-06	5.72e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—stomach cancer	4.02e-06	5.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—stomach cancer	3.96e-06	5.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—stomach cancer	3.93e-06	5.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—stomach cancer	3.79e-06	5.39e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ERCC2—stomach cancer	3.78e-06	5.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—stomach cancer	3.77e-06	5.36e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—stomach cancer	3.76e-06	5.34e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—stomach cancer	3.73e-06	5.31e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—stomach cancer	3.68e-06	5.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—stomach cancer	3.55e-06	5.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—stomach cancer	3.47e-06	4.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—stomach cancer	3.44e-06	4.89e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—stomach cancer	3.36e-06	4.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAV1—stomach cancer	3.28e-06	4.66e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOA1—stomach cancer	3.27e-06	4.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—stomach cancer	3.21e-06	4.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—stomach cancer	3.07e-06	4.36e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—stomach cancer	3e-06	4.27e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—stomach cancer	3e-06	4.27e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—stomach cancer	2.94e-06	4.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—stomach cancer	2.88e-06	4.1e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—stomach cancer	2.83e-06	4.03e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—stomach cancer	2.59e-06	3.68e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—stomach cancer	2.48e-06	3.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—stomach cancer	2.32e-06	3.3e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—stomach cancer	2.27e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—stomach cancer	2.26e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.13e-06	3.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.11e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.81e-06	2.57e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.39e-06	1.98e-05	CbGpPWpGaD
